Skip to main content
. Author manuscript; available in PMC: 2014 Sep 25.
Published in final edited form as: JAMA Ophthalmol. 2014 Jun;132(6):737–741. doi: 10.1001/jamaophthalmol.2014.292

Table 3.

Multiple Linear Regression Predicting 3-Month BSCVA Correcting for Baseline Visual Acuity and Using Covariates

All Cases With 3-mo Visit Coefficient (95% CI), logMAR P Value
Treatment arm (corticosteroid vs placebo) 0.10 (−0.3 to 0.23) .14
Earlier vs later administration of corticosteroid or placebo −0.02 (−0.13 to 0.10) .78
Interaction between treatment arm and administration time −0.21 (−0.37 to −0.05) .01

Abbreviation: BSCVA, best spectacle-corrected visual acuity.